Cargando…

Correction: Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus

Detalles Bibliográficos
Autores principales:	Mitchell, Anna L., Bøe Wolff, Anette, MacArthur, Katie, Weaver, Jolanta U., Vaidya, Bijay, Erichsen, Martina M., Darlay, Rebecca, Husebye, Eystein S., Cordell, Heather J., Pearce, Simon H. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575066/ https://www.ncbi.nlm.nih.gov/pubmed/26382621 http://dx.doi.org/10.1371/journal.pone.0138844

Ejemplares similares

Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
por: Mitchell, Anna L., et al.
Publicado: (2015)

The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease
por: Wolff, Anette Boe, et al.
Publicado: (2021)

Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease
por: Brønstad, Ingeborg, et al.
Publicado: (2011)

A Variant in the BACH2 Gene Is Associated With Susceptibility to Autoimmune Addison's Disease in Humans
por: Pazderska, Agnieszka, et al.
Publicado: (2016)

Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019)

21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules
por: Hellesen, Alexander, et al.
Publicado: (2021)

CTLA-4 as a genetic determinant in autoimmune Addison’s disease
por: Wolff, A S B, et al.
Publicado: (2015)

Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison’s disease
por: Edvardsen, Kine, et al.
Publicado: (2016)

Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2021)

Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019)

Multisteroid LC–MS/MS assay for glucocorticoids and androgens and its application in Addison's disease
por: Methlie, Paal, et al.
Publicado: (2013)

Association of Autoimmune Addison's Disease with Alleles of STAT4 and GATA3 in European Cohorts
por: Mitchell, Anna L., et al.
Publicado: (2014)

Autoimmune Thyroid Disorders in Autoimmune Addison Disease
por: Meling Stokland, Ann-Elin, et al.
Publicado: (2022)

The role of functionally defective rare germline variants of sialic acid acetylesterase in autoimmune Addison's disease
por: Gan, Earn H, et al.
Publicado: (2012)

Primary Ovarian Insufficiency in Women With Addison’s Disease
por: Vogt, Elinor C, et al.
Publicado: (2021)

Residual Corticosteroid Production in Autoimmune Addison Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2020)

GWAS for autoimmune Addison’s disease identifies multiple risk loci and highlights AIRE in disease susceptibility
por: Eriksson, Daniel, et al.
Publicado: (2021)

Oral microbiota in autoimmune polyendocrine syndrome type 1
por: Bruserud, Øyvind, et al.
Publicado: (2018)

Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines
por: Edvardsen, Kine, et al.
Publicado: (2015)

Residual Adrenal Function in Autoimmune Addison’s Disease—Effect of Dual Therapy With Rituximab and Depot Tetracosactide
por: Napier, Catherine, et al.
Publicado: (2019)

Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison’s disease in Sweden
por: Eriksson, Daniel, et al.
Publicado: (2018)

Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function
por: Åkerman, Anna-Karin, et al.
Publicado: (2023)

SAT285 Biomarkers For Cardiovascular Disease And Inflammation Are Altered In Autoimmune Addison's Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2023)

Transcriptional Changes in Regulatory T Cells From Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing
por: Berger, Amund Holte, et al.
Publicado: (2021)

Familial associations for Addison’s disease and between Addison’s disease and other autoimmune diseases
por: Thomsen, Hauke, et al.
Publicado: (2020)

Brain structure in autoimmune Addison’s disease
por: van’t Westeinde, Annelies, et al.
Publicado: (2022)

Impact of Month of Birth on the Risk of Development of Autoimmune Addison's Disease
por: Pazderska, Agnieszka, et al.
Publicado: (2016)

B Cells and Autoantibodies in AIRE Deficiency
por: Wolff, Anette S. B., et al.
Publicado: (2021)

Natural History of Adrenal Steroidogenesis in Autoimmune Addison’s Disease Following Diagnosis and Treatment
por: Napier, Catherine, et al.
Publicado: (2020)

MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes
por: Zurawek, Magdalena, et al.
Publicado: (2016)

Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity
por: Xiao, Yin, et al.
Publicado: (2020)

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
por: Kisand, Kai, et al.
Publicado: (2010)

Genetic variants and risk of endocrine autoimmunity in relatives of patients with Addison’s disease
por: Fichna, Marta, et al.
Publicado: (2023)

Newly diagnosed autoimmune Addison’s disease in a patient with COVID-19 with autoimmune disseminated encephalomyelitis
por: Beshay, Lauren, et al.
Publicado: (2022)

Addison's disease
por: Sarkar, Soumya Brata, et al.
Publicado: (2012)

Addison's Disease
Publicado: (1890)

Addison's Anæmia
Publicado: (1902)

Dr Addison
Publicado: (1860)

Addison’s Disease
por: Rochester, Thos. F.
Publicado: (1880)

Addison’s Disease
por: Rochester, Thos. F.
Publicado: (1880)

Cannot write session to /tmp/vufind_sessions/sess_67v7f4bq714r76t1pgosdt0pae